InspireMD
NSPR

InspireMD (NSPR) earnings history

Most recent quarter

Period end
Jun 30, 2026
EPS actual
−$0.17
EPS estimate
−$0.20
Revenue
$1.8M
Reported
Aug 14, 2026

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2026Aug 14, 2026−$0.20−$0.17+15.00%$1.8MSEC
Q1 2026May 4, 2026−$0.18−$0.16+11.11%$3.4MSEC
Q4 2025Mar 18, 2026−$0.19−$0.14+27.57%$3.1MSEC
Q3 2025Nov 4, 2025−$0.20−$0.17+12.82%$2.5MSEC
Q2 2025Aug 4, 2025−$0.26−$0.26+0.00%$1.8MSEC
Q1 2025May 8, 2025−$0.20−$0.22−10.00%$1.5MSEC
Q4 2024Mar 12, 2025−$0.20−$0.19+2.56%$1.9MSEC
Q3 2024Nov 12, 2024−$0.20−$0.16+20.00%$1.8MSEC
Q2 2024Aug 5, 2024−$0.19−$0.22−15.79%$1.7MSEC
Q1 2024May 13, 2024−$0.18−$0.21−16.67%$1.5MSEC
Q4 2023Mar 5, 2024−$0.19−$0.16+15.79%$1.8MSEC
Q3 2023Nov 6, 2023−$0.14−$0.15−7.14%$1.6MSEC
Q1 2023May 15, 2023−$0.68−$0.53+22.06%$1.2MSEC
Q4 2022Mar 30, 2023−$0.84−$0.60+28.57%$1.0MSEC
Q3 2020Nov 9, 2020−$1.20−$0.90+25.00%$980,000.00
Q2 2020Aug 5, 2020−$5.25−$3.00+42.86%$313,000.00

Quarterly revenue

Q2 2020
$313,000.00
Q3 2020
$980,000.00
Q4 2022
$1.0M
Q1 2023
$1.2M
Q3 2023
$1.6M
Q4 2023
$1.8M
Q1 2024
$1.5M
Q2 2024
$1.7M
Q3 2024
$1.8M
Q4 2024
$1.9M
Q1 2025
$1.5M
Q2 2025
$1.8M
Q3 2025
$2.5M
Q4 2025
$3.1M
Q1 2026
$3.4M
Q2 2026
$1.8M

Frequently asked questions

  • When did InspireMD (NSPR) last report earnings?

    InspireMD last reported on Aug 14, 2026, covering fiscal Q2 2026.

  • Did NSPR beat earnings estimates?

    Yes. InspireMD reported EPS of −$0.17 for Q2 2026 against a −$0.20 estimate — a 15.00% beat.

  • How much revenue did NSPR report last quarter?

    InspireMD reported $1.8M in revenue for Q2 2026, against a consensus estimate of $1.4M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.